On March 14, 2019, FDA made the much-anticipated announcement that it has expanded indications for the MitraClip device to heart failure patients who also have moderate to severe mitral regurgitation (MR).
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
Never miss out on the latest innovative health care content tailored to you.